Bioactive Toxin-Derived Peptides Antimicrobial & Antimycotic Peptides Custom Research Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Alzheimer's & Parkinson's Therapeutic Development Melanogenesis Modulation Anti-Aging & Skin Remodeling Ligand-Directed Targeting Peptides Somatostatin Analogs Kinase Activity Modulators Apoptotic Enzymes Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Thyroid Hormone-Related Insulin/Metabolic Regulation Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Condensation Agents Organic Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Protected Amino Acids, Resins & Reagents Standard Fmoc-Amino Acids Fmoc-Cys(Trt)-OH

DESCRIPTION

Product NameFmoc-Cys(Trt)-OH
SynonymsNα-Fmoc-S-trityl-L-cysteine; Fmoc-S-Trt-L-cysteine
Catalog No.AS2487
CAS Number103213-32-7
Molecular FormulaC37H31NO4S
Molecular Weight585.71 g/mol
SMILESOC(=O)C@HNC(=O)OCC4c5ccccc5-c6ccccc46
Storage TemperatureCool, dry place (≤25°C)
AppearanceWhite powder
Melting Point170–180°C
Specific Rotation+20° ± 2° (C=1 in DMF)
Functional GroupsFmoc-protected α-amino group; Trt-protected thiol; carboxylic acid
Primary ApplicationFmoc solid-phase peptide synthesis (SPPS)

Product Overview

Fmoc-Cys(Trt)-OH is a protected L-cysteine derivative widely used for introducing cysteine residues during Fmoc-based solid-phase peptide synthesis (SPPS).

The α-amino group is protected by Fmoc, while the cysteine side-chain thiol is protected with the acid-labile trityl (Trt) group. This protection helps minimize premature thiol oxidation and other sulfur-related side reactions during repeated coupling and Fmoc-deprotection cycles.

After peptide assembly, the Trt group can be removed during final acidic cleavage to regenerate the free cysteine thiol.

Because cysteine provides a highly versatile sulfur-containing side chain, Fmoc-Cys(Trt)-OH is especially useful for disulfide-containing peptides, cyclic peptides, peptide conjugates, site-selective labeling and ligation-related peptide chemistry.

Researchers working with related protected residues can also explore Standard Fmoc-Amino Acids.

Applications in Peptide Synthesis

ApplicationRole of Fmoc-Cys(Trt)-OH
Fmoc Solid-Phase Peptide SynthesisStandard protected building block for incorporating L-cysteine
Disulfide Peptide SynthesisProvides cysteine residues for controlled disulfide-bond formation after deprotection
Cyclic Peptide SynthesisSupports intramolecular disulfide cyclization strategies
Peptide ConjugationRegenerated thiol can serve as a selective conjugation handle
Fluorescent and Biotin LabelingEnables thiol-selective labeling chemistry
Native Chemical Ligation ResearchCysteine residues are central to many NCL strategies
Structure–Activity Relationship StudiesSupports systematic cysteine introduction or relocation
Custom Peptide SynthesisUsed in linear, cyclic, disulfide-rich and modified research peptides

Sigma-Aldrich specifically lists Fmoc-Cys(Trt)-OH for Fmoc solid-phase peptide synthesis and cites applications including native chemical ligation and cysteine-based glycoconjugation.

Fmoc-Cys(Trt)-OH in Fmoc-SPPS

During Fmoc-SPPS, Fmoc-Cys(Trt)-OH is activated through its carboxyl group and coupled to the growing resin-bound peptide chain.

Following coupling, standard base-mediated Fmoc removal exposes the α-amino group for the next elongation cycle, while the S-Trt group remains attached to the cysteine thiol.

At the end of synthesis, acidic cleavage removes the Trt protecting group and regenerates the free thiol. Earlier comparative work on Fmoc-protected cysteine derivatives showed that Fmoc-Cys(Trt)-OH can be efficiently deprotected under standard high-TFA cleavage conditions.

This orthogonal behavior makes Fmoc-Cys(Trt)-OH one of the standard cysteine building blocks used in conventional Fmoc/tBu peptide synthesis.

For a broader overview of peptide-chain assembly, see Solid-Phase Peptide Synthesis (SPPS): A Practical Guide.

Why Protect Cysteine with Trt?

Cysteine is unusually useful in peptide chemistry because of its thiol group, but the same reactivity can complicate synthesis when the side chain is left unprotected.

Potential problems include:

  • premature oxidation

  • uncontrolled disulfide formation

  • intermolecular cross-linking

  • unwanted thiol reactions

  • modification-related side products

The Trt group provides practical thiol protection during peptide-chain elongation while remaining removable during final acidic cleavage.

This makes Fmoc-Cys(Trt)-OH particularly useful when the final peptide requires a free thiol, controlled disulfide formation or site-selective conjugation.

For more information on specialized protected residues, visit Amino Acids & Peptide Building Blocks.

Disulfide Formation and Peptide Cyclization

After Trt removal, two cysteine thiols can be oxidized to form a disulfide bridge.

Depending on peptide design, this can generate:

  • intramolecular cyclic peptides

  • intermolecular peptide dimers

  • multi-disulfide peptide architectures

  • conformationally constrained bioactive peptides

Disulfide formation can strongly influence peptide conformation, stability and biological activity. Cysteine position should therefore be treated as a structural-design parameter, not simply a sequence requirement.

For peptides containing several cysteine residues, the difficult step may not be cysteine incorporation itself. Instead, achieving the correct disulfide connectivity during oxidative folding can become the dominant challenge.

This is why synthesis strategy, cysteine protection, oxidation conditions and purification should be planned together.

Researchers designing constrained peptides can review Peptide Cyclization Strategies.

Cysteine as a Site-Selective Modification Handle

After Trt removal, the free thiol can be used for selective peptide modification.

Typical applications include:

  • fluorophore attachment

  • biotin conjugation

  • maleimide coupling

  • linker installation

  • peptide–protein conjugation

  • selected probe or drug-conjugation strategies

This makes cysteine particularly valuable when a peptide requires modification at one defined position.

However, introducing cysteine solely as a conjugation handle can also affect local polarity, oxidation behavior, structure and biological activity.

Alan Scientific practical view: if cysteine is introduced for conjugation rather than because it naturally occurs in the sequence, its position should be selected during peptide design rather than automatically placed at the most convenient terminus.

For projects requiring labeling, cyclization or other custom chemistry, Alan Scientific provides Custom Peptide Synthesis, including synthesis, purification, modification and analytical QC.

Cysteine Racemization: A Practical Synthesis Consideration

Cysteine is one of the amino acids for which stereochemical control deserves particular attention during SPPS.

A systematic study of protected cysteine coupling reported that some widely used phosphonium- and aminium-mediated protocols produced 5–33% cysteine racemization under unfavorable conditions. Avoiding preactivation reduced racemization by roughly six- to seven-fold in that model system, and optimized coupling conditions reduced racemization to below 1% per step.

A later practical study confirmed that coupling reagent, base, preactivation time and solvent can all strongly influence cysteine racemization.

This matters because Fmoc-Cys(Trt)-OH itself is not the only determinant of stereochemical integrity.

Alan Scientific practical view: for cysteine-containing peptides, racemization control should be managed through the complete coupling protocol, including activation time, base selection and reaction conditions.

The current Alan Scientific page also lists “Optical Purity <0.3%.” From a technical wording perspective, this would be clearer if internally confirmed as D-isomer / optical impurity ≤0.3% before being incorporated into the expanded Description.

Product Documents

A Safety Data Sheet (SDS / MSDS) is available for this product to support laboratory handling, storage and safety assessment.

📎 MSDS_Fmoc-Cys(Trt)-OH_AS2487.pdf

Related Technical Resources

Learn more about peptide-chain assembly in Solid-Phase Peptide Synthesis (SPPS): A Practical Guide.

Explore additional Standard Fmoc-Amino Acids for peptide synthesis applications.

Explore technical resources covering Amino Acids & Peptide Building Blocks.

Learn more about disulfide and conformational constraint strategies in Peptide Cyclization Strategies.

For complete peptide projects, Alan Scientific provides Custom Peptide Synthesis.

Why Source Peptide Building Blocks from Alan Scientific?

Alan Scientific supplies protected amino acids and peptide building blocks for research and peptide synthesis applications, with competitive pricing, flexible ordering options and peptide synthesis technical support.

Researchers can source individual Fmoc amino acids or combine building-block procurement with Custom Peptide Synthesis according to project requirements.

Research Use Only

10.0% Off

Fmoc-Cys(Trt)-OH

Catalog No: AS2487
Cas No: 103213-32-7

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit